ArticleJournal of the Chinese Medical Association : JCMA2022

Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General Hospital.

Han-Fang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.